We are live on
!
Find out more
MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
39 hedge funds and large institutions have $106M invested in MyoKardia, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
36% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 11
11% more funds holding
Funds holding: 35 → 39 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
23% less capital invested
Capital invested by funds: $137M → $106M (-$31.3M)
Holders
39
Holders Change
+4
Holders Change %
+11.43%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
15
Reduced
11
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$2.22M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.15M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$705K |
| 4 |
CC
Casdin Capital
New York
|
+$650K |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$600K |
